On the finance, would recommend you just keep only one bank and one nbfc.
In Pharma, I would recommend doing 15-15-10 approach. Having too much allocation in just one pharma exposes you the FDA audit risks. So would recommend playing it safe here.
May be you should allocate 10-15% to some small cap ideas (< 500 cr) as well.
| Subscribe To Our Free Newsletter |
